Janux Therapeutics Inc (JANX)
45.02
+0.85
(+1.92%)
USD |
NASDAQ |
Oct 04, 16:00
44.98
-0.04
(-0.09%)
After-Hours: 20:00
Janux Therapeutics Shareholders Equity (Annual): 344.35M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 344.35M |
| December 31, 2022 | 320.74M |
| December 31, 2021 | 366.33M |
| Date | Value |
|---|---|
| December 31, 2020 | -14.64M |
| December 31, 2019 | -7.944M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
-14.64M
Minimum
2020
366.33M
Maximum
2021
201.77M
Average
320.74M
Median
2022
Shareholders Equity (Annual) Benchmarks
| Dynavax Technologies Corp | 622.07M |
| Krystal Biotech Inc | 778.64M |
| Arcus Biosciences Inc | 462.00M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -0.1115M |